Trending...
- Comp-U-Floor ERP to Showcase All-in-One Flooring Software at TISE 2025
- K2 Integrity Appoints Markus Schulz as Chief Technology Officer
- 50th Mount Dora Arts Festival set for Feb 1 and 2, 2024
TAMPA, Fla. - illiNews -- Juventix Regenerative Medical, a leader in regenerative medicine solutions, proudly announces that its Platelet-Rich Plasma (PRP) technology has been featured in a groundbreaking university-published research study. The study, titled "Platelet-Rich Plasma for Rheumatoid Arthritis: A Case Series", published in the peer-reviewed journal Cureus, underscores the efficacy of Juventix PRP in managing rheumatoid arthritis, showcasing its transformative potential in clinical applications.
The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.
Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
More on illi News
Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/
About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.
For more information, visit www.Juventix.com or contact:
More on illi News
📞 (866) 693-4777
✉️ Email: hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.
The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.
Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
- 84% platelet recovery, significantly enhancing platelet-derived growth factor (PDGF) concentrations.
- 10x increase in PDGF levels, with treated PRP reaching 10,844 pg/mL compared to 1,536 pg/mL in untreated samples.
- Minimal contamination of red and white blood cells, ensuring safety and reducing inflammatory risks.
- Optimized pH of 7.5, creating an ideal environment for platelet activation and growth factor release.
- Innovative activation methods, including photoactivation and bio-incubation, transforming PRP into PRF for versatile clinical applications.
More on illi News
- King Dumpsters Canton Launches Affordable, Reliable Dumpster Rental Services in Canton, Ohio
- Matthew Cossolotto's The Joy of Public Speaking – Helping Readers Move from Stage Fright to Stage Delight – Wins 2024 Maincrest Media Book Award
- Lady Bird Laser Spa: Empowering Beauty with Advanced Skin Treatments and Exceptional Service
- Profitable Exciting New Entry Into Emerging Global MOBA Digital Game Arena, Plus New Strategic Partnership with The9 Limited: NIP Group; Stock: NIPG
- The Champagne Connection Podcast Episode Spotlights the Transformative Journey of NASA Scientist
Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/
About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.
For more information, visit www.Juventix.com or contact:
More on illi News
- A Historic Night Awaits: RNHA Celebrating the Power of the Latino Vote at Inauguration 2025
- Namebadges.com Expands Shipping Services to Mexico and Canada
- Keells Leverages Cyntexa and Salesforce to Redefine Customer Loyalty with Digital Innovation
- SomerCor Hires Michael Piazza to Expand SBA 504 Lending Team
- PhaseZero Releases CxCommerce™ 7.0 with Proven Scale for the Largest Enterprises and Affordability for Small Businesses
📞 (866) 693-4777
✉️ Email: hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.
Source: Juventix Regenerative Medical, LLC
0 Comments
Latest on illi News
- WalkerHughes Insurance Expands Footprint With Acquisition of Independent Brokers Agency LLC
- Hawk Tuah VIP Shop launches Exclusive Merchandise line for Viral Meme Fans
- City Of Chicago Responds To S&P Credit Rating Adjustment
- Orcas Island Property Owner Returns Two Prime Waterfront Properties to the Market
- Muench Workshops Welcomes New Partners Luke Dray and Sara Linssen, Announces Retirement of Andy Williams
- Chicago: Mayor Brandon Johnson Announces the Community Growers Program Round 2 Grant Awardees
- NuNorm Announces Stop Soldier Suicide as This Year's EQUAL Grant Recipient
- Darrin Jones: The Creative Force Behind the Trends—Raising Questions About Influence in The Weeknd's Music
- Foresight Practitioner Conference 2025 – Dates, Venue, Speakers, And Competition Finalists Announced
- National Equity Fund (NEF) Achieves Record-Breaking Year with $2.7 Billion in Total Affordable Housing Investments for 2024
- Quad-C Management Completes the Sale of @properties to Compass
- The Real Story Behind the Hemp Bill- Open Letter to Chicago Tribune - Response to Editorial
- Naperville: Public Invited to Open House to Discuss Potential Road Improvements
- InventHelp Inventor Develops New Helmet for Football Players (CHK-1105)
- Latest Updates to Pennsylvania Medical Malpractice and Birth Injury Law
- Best Plant Varieties for Windbreaks and Shelterbelts
- Genuine Hospitality, LLC Expands Leadership Team with Key Appointments
- New-and-Improved Caribbean-Food Website Dishes Out Free Ground-Shipping Offer; Affiliate Program Garnished with Generous Commission
- 50th Mount Dora Arts Festival set for Feb 1 and 2, 2024
- CCHR Cites Newly Released Mind Control Records to Oppose Psychedelics